Related Experiment Videos
Enhanced antiplasmin activity in acute renal failure
British Medical Journal
|October 25, 1975
Summary
Patients with acute renal failure show reduced plasmin-inhibitor activity, impacting fibrinolysis. This suggests a potential link between impaired clot breakdown and kidney dysfunction.
Area of Science:
- Biochemistry
- Nephrology
- Hematology
Background:
- Plasmin-inhibitor activity plays a crucial role in regulating fibrinolysis.
- Acute renal failure (ARF) can affect various physiological processes.
- Understanding fibrinolytic activity in ARF is important for patient management.
Purpose of the Study:
- To investigate plasmatic plasmin-inhibitor activity in patients with acute renal failure.
- To assess the relationship between fibrinolysis and antiplasmin activity in ARF.
Main Methods:
- Assessed plasmatic plasmin-inhibitor activity using the fibrin plate method.
- Evaluated 20 patients with acute renal failure and 12 healthy controls.
- Measured the area of fibrinolysis and correlated it with antiplasmin activity.
Main Results:
- Patients with ARF exhibited significantly reduced fibrinolysis (250.5 +/- 5 mm2) compared to controls (289 +/- 6 mm2; P < 0.001).
- A negative correlation was observed between fibrinolysis area and antiplasmin activity.
- Thirteen ARF patients showed lysis areas at or below the control minimum.
Conclusions:
- Plasmatic antiplasmin activity is diminished in patients with acute renal failure.
- Impaired fibrinolysis is associated with reduced plasmin-inhibitor activity in ARF.
- No correlation was found with fibrin-fibrinogen antigen levels, DIC, or specific causative diseases.